This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bolla M et al. (2002) Long term results with immediate androgen suppression therapy and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomized trial. Lancet 360: 103–108
Holzbeierlein JM et al. (2004) Complications of androgen deprivation therapy: prevention and treatment. Oncology 18: 303–309
Byar DP and Corle DK (1988) Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies. NCI Monogr 7: 165–170
Abrahamsson PA et al. (2005) Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer. Eur Urol 48: 900–905
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Holzbeierlein, J. What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?. Nat Rev Clin Oncol 5, 74–75 (2008). https://doi.org/10.1038/ncponc1003
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1003